Found: 11
Select item for more details and to access through your institution.
Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. 1, doi. 10.7448/IAS.17.1.19246
- By:
- Publication type:
- Article
Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B.
- Published in:
- Vaccines, 2019, v. 7, n. 4, p. 178, doi. 10.3390/vaccines7040178
- By:
- Publication type:
- Article
The role of the different CD3γ domains in TCR expression and signaling.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.978658
- By:
- Publication type:
- Article
Human CD3?, but not CD3d, haploinsufficiency differentially impairs ?d versus aß surface TCR expression.
- Published in:
- BMC Immunology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2172-14-3
- By:
- Publication type:
- Article
Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to Cd300 Molecules Expression.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00836
- By:
- Publication type:
- Article
A Dendritic Cell-Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 166, p. 1, doi. 10.1126/scitranslmed.3004682
- By:
- Publication type:
- Article
MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155245
- By:
- Publication type:
- Article
Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1833, doi. 10.1093/jac/dkv046
- By:
- Publication type:
- Article
Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186602
- By:
- Publication type:
- Article